• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXCELSIOR MEDICAL CORPORATION OMNIFLUSH SYRINGE10ML 0.9% SODIUM CHLORIDE (NACL); 0.9% SODIUM CHLORIDE INJECTION, USP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXCELSIOR MEDICAL CORPORATION OMNIFLUSH SYRINGE10ML 0.9% SODIUM CHLORIDE (NACL); 0.9% SODIUM CHLORIDE INJECTION, USP Back to Search Results
Model Number EM-3513576
Device Problems Contamination (1120); Device Contamination with Chemical or Other Material (2944)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/14/2014
Event Type  malfunction  
Event Description
One of excelsior's (b)(4) reported that a contamination was detected in the syringe.According to the report, the contamination was dark particles in the saline solution and under the white cap at the locking point of the syringe.It should be noted that the syringe was not used on the patient.A review of the original report to excelsior concluded that a medical device report was not required.However, excelsior's distributor filed an initial vigilance report with the (b)(6), excelsior was made aware of the filing on (b)(4) 2014.As a result, excelsior filed a final vigilance report with (b)(4) on (b)(4) 2014.As a result excelsior is now filing this report with the fda.
 
Manufacturer Narrative
Production records for lot 3119062 were reviewed and found to contain no issues that could have caused or contributed to the reported contamination.The subject complaint device was returned to excelsior for evaluation.Visual examination of the complaint syringe confirmed the reported particles in the syringe barrel and white tip cap openings.Retention samples from lot 3119062 were visually inspected and found to contain no defects.Similarly, retention samples from other finished products made with the same syringe and tip cap raw materials were visually examined; no defects were identified during this inspection.Analytical testing on the complaint device was performed by an outside laboratory.The testing identified inorganic and organic materials including carbon, oxygen, sodium, silicone, chlorine, barium and iron.It should be noted that the presence of sodium, chlorine and oxygen is to be expected in the saline solution.The presence of silicone, carbon and oxygen is also to be expected because silicone fluid is used as the lubricant for the syringe barrel wall and rubber piston.A clinical assessment performed by excelsior's medical director, (b)(4), found that the particles would cause no clinical harm in the unlikely event that the particles were injected into the patient.An evaluation of excelsior's incoming raw material inspection and syringe filling processes found that the reported contamination most likely did not occur during processing at excelsior medical.An investigation conducted by the tip cap supplier found that the reported contamination most likely did not occur during processing of the particular tip cap lot.The syringe supplier conducted an investigation into the reported issue, but could not identify a cause for the reported contamination.Based on the above assessments, excelsior could not identify a definitive root cause for the reported event.The reported issue appears to be an isolated incident, with this report being the only event for lot 3119062.Excelsior utilizes automated inspection systems to detect several attributes including foreign matter during production.Faulty syringes detected by the automated inspection systems are rejected during processing.In addition, the syringe supplier is currently working on implementing an automated inspection system during the assembly process of the syringe barrels.The expected implementation date at the syringe supplier is (b)(4) 2015.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIFLUSH SYRINGE10ML 0.9% SODIUM CHLORIDE (NACL)
Type of Device
0.9% SODIUM CHLORIDE INJECTION, USP
Manufacturer (Section D)
EXCELSIOR MEDICAL CORPORATION
1933 heck avenue
neptune NJ 07753
Manufacturer (Section G)
EXCELSIOR MEDICAL CORPORATION
1933 heck avenue
neptune NJ 07753
Manufacturer Contact
john linfante
1933 heck avenue
neptune, NJ 07753
7326436088
MDR Report Key4219580
MDR Text Key4974955
Report Number2027791-2014-00004
Device Sequence Number1
Product Code NGT
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K962938
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Distributor
Reporter Occupation Other
Type of Report Initial
Report Date 10/31/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/01/2016
Device Model NumberEM-3513576
Device Lot Number3119062
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/14/2014
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 08/08/2014
Initial Date FDA Received11/03/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/29/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-